Liraglutide as an Additional Treatment to Insulin in Patients with Type 1 Diabetes Mellitus—A 52-Week Randomized Double-Blinded Placebo-Controlled Clinical Trial

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 3-LB ◽  
Author(s):  
PARESH DANDONA ◽  
HUSAM GHANIM ◽  
NITESH D. KUHADIYA ◽  
TANVI SHAH ◽  
JEANNE M. HEJNA ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Clinical Trial ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Additional Treatment ◽  
Controlled Clinical Trial ◽  
Double Blinded

F.47. Ingested IFN-alpha2A Prolongs the 'Honeymoon' Phase in New Onset Type 1 Diabetes Mellitus (T1D) in a Phase II Randomized Clinical Trial (RCT)

2009 ◽  
Vol 131 ◽  
pp. S107
Author(s):  
Kristina Rother ◽  
Rebecca Brown ◽  
Elizabeth Wright ◽  
Miriam Morales ◽  
Carol Campbell ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Clinical Trial ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Randomized Clinical Trial ◽  
Phase Ii ◽  
Onset Type ◽  
New Onset

Liraglutide as Additional Treatment to Insulin in Obese Patients with Type 1 Diabetes Mellitus

2013 ◽  
Vol 19 (6) ◽  
pp. 963-967 ◽  
Author(s):  
Nitesh Kuhadiya ◽  
Ritu Malik ◽  
Natalie Bellini ◽  
Jane Patterson ◽  
Andrea Traina ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Additional Treatment ◽  
Obese Patients

scholarly journals Efficacy of Insulclock in Patients with Poorly Controlled Type 1 Diabetes Mellitus: A Pilot, Randomized Clinical Trial

2020 ◽  
Vol 22 (9) ◽  
pp. 686-690
Author(s):  
Fernando Gomez-Peralta ◽  
Cristina Abreu ◽  
Sara Gomez-Rodriguez ◽  
Margarita Cruz-Bravo ◽  
Cristina María-Sanchez ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Clinical Trial ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Randomized Clinical Trial
Sign in / Sign up

Export Citation Format

Share Document